Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1 study found for:    19365288 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Recruiting Uncontrolled Lower Respiratory Symptoms in the WTC Survivor Program
Conditions: Lung Diseases;   Medication Compliance
Interventions: Drug: Fluticasone propionate 230mcg for 3 Months;   Drug: Current Treatment or no treatment;   Drug: Salmeterol 21mcg for 3 Months

Indicates status has not been verified in more than two years